Prelude Capital Management’s Bluegreen Vacations Holding Corporation BVH Stock Holding History

Prelude Capital Management’s Portfolio BVH Stock Details BVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,271	Closed	-$1.52M	–	1590
2023 Q4	$1.52M	Buy	+20,271	New	+$1.18M	0.1%	221
2021 Q2	–	Sell	-12,028	Closed	-$223K	–	2056
2021 Q1	$223K	Buy	+12,028	New	+$189K	0.01%	1283
2019 Q2	–	Sell	-1,060	Closed	-$31K	–	2242
2019 Q1	$31K	Buy	+1,060	New	+$32.4K	﹤0.01%	1251
2018 Q3	–	Sell	-3,263	Closed	-$147K	–	2118
2018 Q2	$147K	Sell	3,263 -899	-22%	-$41.5K	0.01%	829
2018 Q1	$192K	Buy	4,162 +2,060	+98%	+$91.6K	0.01%	692
2017 Q4	$84K	Buy	2,102 +422	+25%	+$16.6K	0.01%	830
2017 Q3	$62K	Buy	+1,680	New	+$57.1K	0.01%	1038

Other funds holding BVH

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Prelude Capital Management's BVH Position: Q1 2024 in Review

Prelude Capital Management sold out of Bluegreen Vacations Holding Corporation (BVH) in Q1 2024, closing a stake of 20,271 shares — an estimated $1.52M sold.

Prelude Capital Management first reported a position in BVH in Q3 2017 and held it in 7 quarters. The position peaked at $1.52M in Q4 2023. 2 funds tracked by Wall St. Rank hold BVH as of Q1 2024.

Prelude Capital Management reported no remaining Bluegreen Vacations Holding Corporation position as of Q1 2024 after selling out during the quarter.
Prelude Capital Management sold 20,271 Bluegreen Vacations Holding Corporation shares in Q1 2024, an estimated $1.52M.
Prelude Capital Management first reported a position in Bluegreen Vacations Holding Corporation in Q3 2017 and held it in 7 quarters.
Prelude Capital Management's Bluegreen Vacations Holding Corporation position peaked at $1.52M in Q4 2023.
2 funds tracked by Wall St. Rank held Bluegreen Vacations Holding Corporation as of Q1 2024.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.